Clinical Trial Update: First in Human Trial to Assess the Feasibility and Preliminary Safety of Adjunctive Treatment with the HemoSystem REBOOT in Critically Ill Patients with Sepsis-induced Immunosuppression [NA]

View source ↗

Summary

This clinical trial update announces a first-in-human study to assess feasibility and preliminary safety of HemoSystem REBOOT as an adjunctive therapy in critic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• HemoSystem REBOOT

Snippet

Sponsor: hemotune AG | Conditions: Septic Shock | NA | Status: NOT_YET_RECRUITING